GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
A

Active Biotech AB publ ACTI.ST · SEK

Health Care · Nasdaq Stockholm · 🇸🇪 Sweden

Compare

3.45

-4.17%

Close of 9 Nov 2026, in SEK

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About Active Biotech AB publ

Its shares trade on Nasdaq Stockholm under the ticker ACTI.ST. It has been listed since 1 December 1986. In the fiscal year to 31 December 2021, it reported revenue of SEK 6.2m and a net loss of SEK 49.9m. At that date it held total assets of SEK 56.8m and shareholders' equity of SEK 46.7m.

Active Biotech AB develops pharmaceutical preparations. The company is headquartered in Lund, Skane. The project portfolio comprises both small, orally active immunomodulatory molecules and antibody-based immunotherapy.

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Sector
Health Care
Industry
Biotechnology
Listed since
1 Dec 1986
Employees
11

Leadership

Pay as last reported

  • Mr. Michael ShalmiChairman of the Board, since 2019
  • Ms. Helen TuvessonPresident, Chief Executive Officer, since 2017
  • Mr. Hans KolamChief Financial Officer
  • Ms. Helena ErikssonChief Scientific Officer
  • Mr. Aleksandar DanilovskiDirector
  • Mr. Axel GlasmacherDirector
  • Prof. Uli HacksellDirector
  • Hr. Peter ThelinIndependent DirectorSEK 125,000

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
0
Environment
0
Social
0
Governance
0

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • Active Biotech AB (publ) has several strengths that contribute to its success:

Weaknesses

  • Active Biotech AB (publ) faces some weaknesses that pose challenges:

Opportunities

  • Active Biotech AB (publ) can leverage the following opportunities:

Threats

  • Active Biotech AB (publ) faces several threats that could impact its business:

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.